Vitros chemistry and immunoassay analyzer testing reagents and consumables
Ended Awarded Last action
- Contract number
- HT941026FE014
- Awardee
-
Ortho Clinical Diagnostics K.K. UEI E35NFBSEY3X4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $26,509
Award facts
- Contract value 100% obligated
- $26,508.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Japan
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $26.5K firm fixed-price blanket purchase agreement (BPA) call to Ortho Clinical Diagnostics K.K. on January 5, 2026, for VITROS chemistry and immunoassay analyzer testing reagents and consumables, with completion targeted for January 30, 2026. The award carries no socioeconomic set-aside designation and will be performed in Japan. Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions provider Ortho Clinical Diagnostics, is a registered for-profit manufacturer currently eligible to receive federal awards through February 2026.
This contract call is issued under one of the vendor's existing BPAs with the Defense Health Agency, a $2.875M single-award vehicle established July 1, 2024, through June 30, 2029, for VITROS 7600 laboratory testing equipment consumables supporting U.S. military medical facilities throughout Japan, including Yokota Air Base and other installations. Ortho Clinical Diagnostics K.K. has been the primary supplier of laboratory diagnostic materials to the Defense Health Agency, the Department of Navy Bureau of Medicine and Surgery, and Pacific Air Forces since 2021, maintaining four active indefinite-delivery vehicles and delivering critical testing reagents and supplies to naval hospitals in Yokosuka, Atsugi, Sasebo, and Iwakuni, as well as air force bases at Misawa and Yokota in support of active duty personnel, dependents, and retirees.
Quick answers
Who was awarded contract HT941026FE014?
HT941026FE014 was awarded to Ortho Clinical Diagnostics K.K. by Defense Health Agency (Department of Defense) on January 5, 2026.
How much is contract HT941026FE014 worth?
The government has obligated $26,509 on HT941026FE014.
Is contract HT941026FE014 an order under another contract?
Yes. HT941026FE014 is a BPA call under HT941024A0007, a blanket purchase agreement.
Was contract HT941026FE014 competed?
The extent of competition for HT941026FE014 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award